Industry News
Horses for courses for Bioeffectives
Bioeffectives show promise as effective treatment of equine gastric ulcers and as a replacement for antibiotics in poultry feed. [ + ]
No pain for Xenome
Synthetic venom peptide shows promise in trials [ + ]
Spine fusion for Mesoblast
Mesoblast's stem cells effective method for cervical spine fusion [ + ]
QRXPharma writes off
QRxPharma reports $36 million deficit [ + ]
Market in sight for Pharmaxis
Pharmaxis concludes Phase 3 trial of Bronchitol [ + ]
Happy as a pig
Imugene reports early PRRS vaccine trial results [ + ]
Good dose for Viralytics
Viralytics progresses through Phase 1 trial of Cavatak [ + ]
Anadis fights flu
Anadis shows proof-of-principle for spray-based 'flu fighter' [ + ]
Investment boost for UniQuest start-up companies
Two companies that were established to develop discoveries from the Australian Institute for Bioengineering and Nanotechnology (AIBN) at UQ have received funding to boost their research priorities.
[ + ]US Pharmacopeia achieves ISO accreditation for Certified Reference Materials
The US Pharmacopeial Convention has achieved accreditation from ACLASS to the ISO Guide 34 for reference material producers as an internationally accredited producer of Certified Reference Materials.
[ + ]Aldridge quits Peplin
Peplin appoints new CEO and president/CMO [ + ]
Patent no loss of MatrixView
MatrixView awarded European patent for data management technology [ + ]
$3 million for Chagas research
Murdoch University and Epichem get $3 million Chagas research boost [ + ]
Genentech rejects Roche bid
US biotech Genentech rejects $43.7 billion takeover deal [ + ]
Acrux-Organon partnership dropped
Schering-Plough cancels two projects with Acrux [ + ]
